Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Twist Bioscience Corp (TWST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C11291)・商品コード:DATA904C11291
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:44
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single variant libraries, clonal perfect genes and non-clonal fragments, target enrichment solutions, DNA data storage, among others. The company’s products are used in the fields of medicine, agriculture, industrial chemicals and data storage. The company operates in the US, Europe, Israel, and Singapore. Twist Bioscience is headquartered in San Francisco, California, the US.

Twist Bioscience Corp (TWST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Twist Bioscience Raises USD33 Million in Venture Financing 15
Twist Bioscience Raises USD2.6 Million Financing 16
Twist Bioscience Raises USD61 Million in Series D Venture Financing 17
Twist Bioscience Raises USD37 Million in Series C Venture Financing 19
Twist Bioscience Raises USD26 Million in Series B Financing 21
Twist Bioscience Secures USD9.11 Million in Series A Funding 22
Twist Bioscience Raises US$4.7 Million In Series A Financing 23
Partnerships 24
Twist Bioscience and Desktop Genetics Enter into Partnership 24
Genome Compiler Enters into Integration Agreement with Addgene 25
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 26
Equity Offering 27
Twist Bioscience Prices IPO of Shares for USD70 Million 27
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 28
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 29
Twist Bioscience Raises USD50 Million in Private Placement of Shares 30
Twist Bioscience Corp – Key Competitors 31
Twist Bioscience Corp – Key Employees 32
Twist Bioscience Corp – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Strategy And Business Planning 34
Feb 28, 2018: Twist Bioscience Expands North American Presence With Office in San Diego, California 34
Corporate Communications 35
Oct 24, 2018: Twist Bioscience names Ray Tabibiazar, M.D., as senior vice president, corporate development and business strategy 35
Jun 20, 2018: Twist Bioscience Appoints Jim Thorburn CFO And Aaron Sato As CSO Of Pharma 36
Legal and Regulatory 37
Oct 29, 2018: Agilent sends letter to the SEC regarding Material Misstatements in Twist Bioscience’s S-1 registration statement 37
Sep 18, 2018: Agilent Files New Complaint Against Twist Bioscience Regarding Stolen Agilent Confidential Documents 38
Government and Public Interest 39
Sep 18, 2018: Twist Bioscience Responds to Agilent’s Latest Specious Claims 39
Jul 17, 2017: Sphere Fluidics and Partners Win Major InnovateUK Grant to Develop the World’s First Desktop Genome Editing System 40
Product News 41
Jun 18, 2018: Twist Bioscience Expands Human Core Exome and Custom Next-Generation Sequencing Solutions with High Throughput Offering 41
Feb 14, 2018: Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Genomics and Clinical Researchers Conducting Next-Generation Sequencing 42
Other Significant Developments 43
Jul 11, 2017: Quintara Biosciences Partners with Twist Bioscience to Launch New Gene Fragment and Cloning Services, qBlocks and qGenes 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Key Facts 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Twist Bioscience Raises Additional USD27 Million in Venture Financing 13
Twist Bioscience Raises USD33 Million in Venture Financing 15
Twist Bioscience Raises USD2.6 Million Financing 16
Twist Bioscience Raises USD61 Million in Series D Venture Financing 17
Twist Bioscience Raises USD37 Million in Series C Venture Financing 19
Twist Bioscience Raises USD26 Million in Series B Financing 21
Twist Bioscience Secures USD9.11 Million in Series A Funding 22
Twist Bioscience Raises US$4.7 Million In Series A Financing 23
Twist Bioscience and Desktop Genetics Enter into Partnership 24
Genome Compiler Enters into Integration Agreement with Addgene 25
Genome Compiler Enters into Co-Development Agreement with De Novo DNA 26
Twist Bioscience Prices IPO of Shares for USD70 Million 27
Twist Bioscience Raises USD1 Million in Private Placement of Series D Preferred Shares 28
Twist Bioscience Raises USD11 Million in Private Placement of Series D Preferred Shares 29
Twist Bioscience Raises USD50 Million in Private Placement of Shares 30
Twist Bioscience Corp, Key Competitors 31
Twist Bioscience Corp, Key Employees 32
Twist Bioscience Corp, Other Locations 33
Twist Bioscience Corp, Subsidiaries 33

List of Figures
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Twist Bioscience Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Twist Bioscience Corp, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C11291)販売に関する免責事項を必ずご確認ください。
★調査レポート[Twist Bioscience Corp (TWST):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆